{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T18:24:11Z","timestamp":1775845451843,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-026-00693-7","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:35:52Z","timestamp":1775842552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SSTR2 expression in EBV-positive and EBV-negative lymphomas"],"prefix":"10.1007","volume":"19","author":[{"given":"Nivaz","family":"Brar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Barrios-Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory W.","family":"Charville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward L.","family":"Briercheck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Valvert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"4","key":"693_CR1","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2967\/jnumed.106.035667","volume":"48","author":"M Gabriel","year":"2007","unstructured":"Gabriel M, Decristoforo C, Kendler D et al (2007) 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 48(4):508\u2013518. https:\/\/doi.org\/10.2967\/jnumed.106.035667","journal-title":"J Nucl Med"},{"issue":"9","key":"693_CR2","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1023\/a:1008383132024","volume":"11","author":"S Ricci","year":"2000","unstructured":"Ricci S, Antonuzzo A, Galli L et al (2000) Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide. Ann Oncol 11(9):1127\u20131130. https:\/\/doi.org\/10.1023\/a:1008383132024","journal-title":"Ann Oncol"},{"issue":"3","key":"693_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-015-1459-3","volume":"130","author":"JR Menke","year":"2015","unstructured":"Menke JR, Raleigh DR, Gown AM, Thomas S, Perry A, Tihan T (2015) Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathol 130(3):441\u2013443. https:\/\/doi.org\/10.1007\/s00401-015-1459-3","journal-title":"Acta Neuropathol"},{"issue":"1","key":"693_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20308-8","volume":"12","author":"M Lechner","year":"2021","unstructured":"Lechner M, Schartinger VH, Steele CD et al (2021) Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy. Nat Commun 12(1):117. https:\/\/doi.org\/10.1038\/s41467-020-20308-8","journal-title":"Nat Commun"},{"issue":"5","key":"693_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.arcmed.2014.06.001","volume":"45","author":"JH Lee","year":"2014","unstructured":"Lee JH, Kim Y, Choi JW, Kim YS (2014) Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin\u2019s lymphoma: a meta-analysis. Arch Med Res 45(5):417\u2013431. https:\/\/doi.org\/10.1016\/j.arcmed.2014.06.001","journal-title":"Arch Med Res"},{"issue":"10","key":"693_CR6","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1182\/bloodadvances.2021004347","volume":"5","author":"F Valvert","year":"2021","unstructured":"Valvert F, Silva O, Sol\u00f3rzano-Ortiz E et al (2021) Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countries. Blood Adv 5(10):2447\u20132455. https:\/\/doi.org\/10.1182\/bloodadvances.2021004347","journal-title":"Blood Adv"},{"issue":"7","key":"693_CR7","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave SS, de Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint A Jr, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"issue":"11","key":"693_CR8","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman AL, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles G, San-Miguel J, Seymour JF, Treon SP, Vose JM, Zucca E, Advani R, Ansell S, Au WY, Barrionuevo C, Bergsagel L, Chan WC, Cohen JI, d\u2019Amore F, Davies A, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim WS, Kumar S, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, Lopez-Guillermo A, Mateos MV, Macintyre E, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris M, Pro B, Rajkumar V, Rosen ST, Sander B, Sehn L, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani PL, Dreyling M, Scott DW, Winter JN, Zelenetz AD (2022) The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140(11):1229\u20131253. https:\/\/doi.org\/10.1182\/blood.2022015851","journal-title":"Blood"},{"key":"693_CR9","doi-asserted-by":"publisher","unstructured":"Marinelli RJ, Montgomery K, Liu CL et al (2008) The stanford tissue microarray database. Nucleic Acids Res 36:D871\u2013877. https:\/\/doi.org\/10.1098\/nar\/gkm861","DOI":"10.1098\/nar\/gkm861"},{"issue":"6","key":"693_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ijc.2910500613","volume":"50","author":"JC Reubi","year":"1992","unstructured":"Reubi JC, Waser B, van Hagen M et al (1992) In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer 50(6):895\u2013900. https:\/\/doi.org\/10.1002\/ijc.2910500613","journal-title":"Int J Cancer"},{"issue":"2","key":"693_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/0284186X.2017.1342864","volume":"57","author":"T Ruuska","year":"2018","unstructured":"Ruuska T, Ram\u00edrez Escalante Y, Vaittinen S et al (2018) Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at\u00a068Ga-DOTANOC PET\/CT imaging. Acta Oncol 57(2):283\u2013289. https:\/\/doi.org\/10.1080\/0284186X.2017.1342864","journal-title":"Acta Oncol"},{"key":"693_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.710900","volume":"11","author":"T Juntikka","year":"2021","unstructured":"Juntikka T, Vaittinen S, Vahlberg T, Jyrkki\u00f6 S, Minn H (2021) Somatostatin receptors and chemokine receptor CXCR4 in lymphomas: a histopathological review of six lymphoma subtypes. Front Oncol 11:710900. https:\/\/doi.org\/10.3389\/fonc.2021.710900","journal-title":"Front Oncol"},{"key":"693_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.anndiagpath.2019.06.007","volume":"41","author":"PH Chen","year":"2019","unstructured":"Chen PH, Yang Y, O\u2019Malley DP, Xu ML (2019) Clinicopathologic characteristics and novel biomarkers of aggressive B-cell lymphomas in the nasopharynx. Ann Diagn Pathol 41:129\u2013135. https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.06.007","journal-title":"Ann Diagn Pathol"},{"issue":"12","key":"693_CR14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/jcp.2007.050146","volume":"60","author":"G Kapatai","year":"2007","unstructured":"Kapatai G, Murray P (2007) Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol 60(12):1342\u20131349. https:\/\/doi.org\/10.1136\/jcp.2007.050146","journal-title":"J Clin Pathol"},{"key":"693_CR15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021346","author":"M Leopizzi","year":"2023","unstructured":"Leopizzi M, Mundo L, Messina E et al (October 2023) Epstein-Barr virus encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma. Blood. https:\/\/doi.org\/10.1182\/blood.2023021346","journal-title":"Blood"},{"issue":"4","key":"693_CR16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","volume":"35","author":"MA Weniger","year":"2021","unstructured":"Weniger MA, K\u00fcppers R (2021) Molecular biology of Hodgkin lymphoma. Leukemia 35(4):968\u2013981. https:\/\/doi.org\/10.1038\/s41375-021-01204-6","journal-title":"Leukemia"},{"issue":"14","key":"693_CR17","doi-asserted-by":"publisher","first-page":"8227","DOI":"10.1128\/JVI.01089-13","volume":"87","author":"D Iwakiri","year":"2013","unstructured":"Iwakiri D, Minamitani T, Samanta M (2013Jul) Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation. J Virol 87(14):8227\u20138234 (PMID: 23698301)","journal-title":"J Virol"},{"issue":"52","key":"693_CR18","doi-asserted-by":"publisher","first-page":"22421","DOI":"10.1073\/pnas.0911676106","volume":"106","author":"A Canaan","year":"2009","unstructured":"Canaan A, Haviv I, Urban AE, Schulz VP, Hartman S, Zhang Z, Palejev D, Deisseroth AB, Lacy J, Snyder M, Gerstein M, Weissman SM (2009Dec 29) EBNA1 regulates cellular gene expression by binding cellular promoters. Proc Natl Acad Sci U S A 106(52):22421\u201322426 (PMID: 20080792)","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"693_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1182\/blood-2025-326","volume":"146","author":"I Kong","year":"2025","unstructured":"Kong I, Van Besien H, Clark S, Sun S, Zappasodi R, Roth L, Cesarman E (2025) Epigenetic silencing via SP140 and H3K27me3 restricts immunogenic viral antigen expression in EBV+ lymphomas. Blood 146(1):326","journal-title":"Blood"},{"key":"693_CR20","unstructured":"Swerdlow SH, Campo E, Harris HL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) (2017) World health organization classificiation of tumours of haematopoietic and lymphoid tissues (Revised 4th edition). IARC: Lyon"},{"issue":"1","key":"693_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/bjh.14201","volume":"175","author":"YN Blaker","year":"2016","unstructured":"Blaker YN, Spetalen S, Brodtkorb M et al (2016) The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era. Br J Haematol 175(1):102\u2013114. https:\/\/doi.org\/10.1111\/bjh.14201","journal-title":"Br J Haematol"},{"issue":"6","key":"693_CR22","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1210\/en.2007-1525","volume":"149","author":"J Torrisani","year":"2008","unstructured":"Torrisani J, Hanoun N, Laurell H, Lopez F, Maoret JJ, Souque A, Susini C, Cordelier P, Buscail L (2008Jun) Identification of an upstream promoter of the human somatostatin receptor, hSSTR2, which is controlled by epigenetic modifications. Endocrinology 149(6):3137\u20133147 (PMID: 18325993)","journal-title":"Endocrinology"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00693-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00693-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00693-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:35:54Z","timestamp":1775842554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00693-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["693"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00693-7","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, informed consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"For this type of study, consent for publication is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14"}}